Abbott Laboratories News
Pfizer Snags Hospira in $16 Billion Deal
Pfizer seeking growth with injectables and biosimilars therapies.
Drug Maker Doesn't Want Public to Think 'Popping Vicodin is Trendy or Cool'
A line of popular and controversial t-shirts are the focus of a lawsuit in which drug maker AbbVie Inc. is saying they don't want the public to think "popping Vicodin is a cool 'in' thing to do." Biopharmaceutical company AbbVie is suing Kitson, which runs trendy fashion boutiques under the company
Belviq Hits Market: Diet Pills Then and Now
With more than 36 percent of American adults now classified as obese according to the Centers for Disease Control and Prevention, and the numbers still climbing, doctors are clamoring for more pharmaceuticals to treat their patients. Last year, the Federal Drug Administration obliged by approving
7 Richest Snitches: Time to Rat Out Your Boss?
Ever dream of getting rich by blowing the whistle on your boss? People have—most recently Bradley Birkenfeld, the ex-banker whom the IRS paid a record $104 million for ratting out his former banking bosses who had helped U.S. clients to hide money in Swiss accounts. Have any other blowers cashed in
Sears Chief, Other CEOs Continue High-Flying Ways
It's good to be the king--or in this case, CEO of Sears. At the same time the troubled retailer is shutting stores and laying off "associates," it is paying $800,000 a year to waft Chief Executive Louis J. D'Ambrosio between Philadelphia, where he lives, and Chicago, where he works, by private jet.
Social Security Boost, Housing, Earnings Reports Up
Dow futures were flat this morning a day after the index rose a 180 points. Joining me now to discuss the business headlines at this hour celebrate and from Bloomberg TV not to CEO Stephanie good morning so we've got. Busy morning here let's start with an announcement a lot of people are talking
New Lung Cancer Pill Highlights Improved Way of Treating Patients
A new drug to combat a certain type of lung cancer is being hailed today as an "amazing development" by medical experts. The drug crizotinib (Xalkori), manufactured by Pfizer and approved last week by the Food and Drug Administration, is intended for a small number of patients. The twice-daily
Thanks to the Fed, you'll only get income with extra risk
You'll have an easier time finding Sasquatch than finding income from your savings these days. What's worse, you'll be searching for a long time: The Federal Reserve says it plans to keep rates lower than the Loch Ness Monster's basement until June 2013. Once upon a time, you could get higher rates
Corporations add their know-how to charitable efforts
When Judith Cruz started as executive director of the Treasure Coast Food Bank in Fort Pierce, Fla., in 2009, the food bank was helping serve more than 42,000 meals a week. But with many residents of southeastern Florida struggling to put food on the table because of the economic downturn, she knew
Mini flash crashes worry traders
Mini flash crashes still occur routinely with individual stocks, a sign some of the problems that contributed to the short-circuiting of the markets more than a year ago are still happening. Despite efforts to prevent another flash crash, the infamous day on May 6, 2010, when the Dow Jones